...
首页> 外文期刊>Bone >Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease.
【24h】

Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease.

机译:慢性肾脏病大鼠模型中与骨脆性相关的皮质骨化学成分的变化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Bone fragility is a complication of chronic kidney disease (CKD). Patients on dialysis have higher risk of fracture than the general population, but the reason remains obscure. Bone strength is determined by bone mass and bone quality. Although factors affecting bone quality include microarchitecture, remodeling activity, mineral content, and collagen composition, it remains unclear which factor is critically important for bone strength in CKD. We conducted an in vivo study to elucidate the factors that reduce bone mechanical property in CKD. Rats underwent thyroparathyroidectomy and progressive partial nephrectomy (TPTx-Nx). Bone mechanical property, bone mineral density (BMD), and cortical bone chemical composition (all in femur) as well as histomorphometry (in tibia) were determined. The storage modulus, which is a mechanical factor, was reduced in CKD model rats compared with controls that underwent thyroparathyroidectomy alone (TPTx). There were no differences in BMD and histomorphometric parameters between groups. However, cortical bone chemical composition differed: mineral to matrix ratio and carbonate substitution increased whereas crystallinity decreased in TPTx-Nx. In addition, enzymatic crosslinks ratio and pentosidine to matrix ratio also increased. These changes were significant in TPTx-Nx rats with most impaired renal function. Stepwise multiple regression analysis identified mature to immature crosslink ratio and crystallinity as independent contributors to storage modulus. Deteriorated bone mechanical properties in CKD may be caused by changes in chemical composition of the cortical bone, and is independent of BMD or cancellous bone microarchitecture.
机译:骨脆性是慢性肾脏疾病(CKD)的并发症。透析患者的骨折风险比一般人群高,但原因仍然不清楚。骨强度取决于骨量和骨质量。尽管影响骨骼质量的因素包括微结构,重塑活性,矿物质含量和胶原蛋白组成,但仍不清楚哪个因素对CKD的骨骼强度至关重要。我们进行了一项体内研究,以阐明降低CKD骨力学性能的因素。大鼠接受甲状腺甲状旁腺切除术和进行性部分肾切除术(TPTx-Nx)。确定了骨力学性能,骨矿物质密度(BMD)和皮质骨化学成分(全部在股骨中)以及组织形态测定法(在胫骨中)。与仅进行甲状腺副甲状腺切除术(TPTx)的对照相比,CKD模型大鼠的作为机械因素的储能模量降低了。两组之间的BMD和组织形态计量学参数无差异。但是,皮质骨化学成分不同:TPTx-Nx中矿物质与基质的比率和碳酸盐取代度增加,而结晶度下降。另外,酶交联比和戊糖对基质的比也增加了。这些变化在肾功能最弱的TPTx-Nx大鼠中很明显。逐步多元回归分析确定了成熟到不成熟的交联比和结晶度是储能模量的独立因素。 CKD中骨骼力学性能的下降可能是由皮质骨化学成分的变化引起的,并且与BMD或松质骨微结构无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号